JP2009542216A - サンプルから事前に抽出せずに高分子を修飾する方法 - Google Patents
サンプルから事前に抽出せずに高分子を修飾する方法 Download PDFInfo
- Publication number
- JP2009542216A JP2009542216A JP2009518328A JP2009518328A JP2009542216A JP 2009542216 A JP2009542216 A JP 2009542216A JP 2009518328 A JP2009518328 A JP 2009518328A JP 2009518328 A JP2009518328 A JP 2009518328A JP 2009542216 A JP2009542216 A JP 2009542216A
- Authority
- JP
- Japan
- Prior art keywords
- dna
- sample
- tissue
- purification
- bisulfite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 203
- 229920002521 macromolecule Polymers 0.000 title claims abstract description 20
- 238000000605 extraction Methods 0.000 title claims abstract description 13
- 229920000642 polymer Polymers 0.000 claims abstract description 18
- 239000000126 substance Substances 0.000 claims abstract description 12
- 108020004414 DNA Proteins 0.000 claims description 108
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 48
- 210000001519 tissue Anatomy 0.000 claims description 48
- 238000000746 purification Methods 0.000 claims description 44
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 40
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 39
- 230000004048 modification Effects 0.000 claims description 36
- 238000012986 modification Methods 0.000 claims description 36
- 239000003153 chemical reaction reagent Substances 0.000 claims description 30
- 210000002700 urine Anatomy 0.000 claims description 26
- 238000005869 desulfonation reaction Methods 0.000 claims description 22
- 230000006326 desulfonation Effects 0.000 claims description 20
- 210000004027 cell Anatomy 0.000 claims description 18
- 239000006166 lysate Substances 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
- 150000002632 lipids Chemical class 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 150000001720 carbohydrates Chemical class 0.000 claims description 13
- 235000014633 carbohydrates Nutrition 0.000 claims description 13
- 238000011534 incubation Methods 0.000 claims description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- 230000015572 biosynthetic process Effects 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 238000001574 biopsy Methods 0.000 claims description 9
- 238000005119 centrifugation Methods 0.000 claims description 9
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 8
- 210000001124 body fluid Anatomy 0.000 claims description 8
- 239000010839 body fluid Substances 0.000 claims description 8
- 230000001413 cellular effect Effects 0.000 claims description 8
- 238000006481 deamination reaction Methods 0.000 claims description 8
- 239000002207 metabolite Substances 0.000 claims description 8
- 230000011987 methylation Effects 0.000 claims description 8
- 238000007069 methylation reaction Methods 0.000 claims description 8
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical group O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 6
- 238000005576 amination reaction Methods 0.000 claims description 6
- 230000006287 biotinylation Effects 0.000 claims description 6
- 238000007413 biotinylation Methods 0.000 claims description 6
- 230000009615 deamination Effects 0.000 claims description 6
- 239000002502 liposome Substances 0.000 claims description 6
- 210000000056 organ Anatomy 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 6
- 239000005909 Kieselgur Substances 0.000 claims description 5
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical group [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000000543 intermediate Substances 0.000 claims description 5
- 239000000377 silicon dioxide Substances 0.000 claims description 5
- -1 RNAlater® Natural products 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 4
- 108020000946 Bacterial DNA Proteins 0.000 claims description 3
- 108050001049 Extracellular proteins Proteins 0.000 claims description 3
- 108020005196 Mitochondrial DNA Proteins 0.000 claims description 3
- 108091093105 Nuclear DNA Proteins 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 102000035195 Peptidases Human genes 0.000 claims description 3
- 108020005202 Viral DNA Proteins 0.000 claims description 3
- 238000001261 affinity purification Methods 0.000 claims description 3
- 210000000170 cell membrane Anatomy 0.000 claims description 3
- 239000000356 contaminant Substances 0.000 claims description 3
- 230000022811 deglycosylation Effects 0.000 claims description 3
- 230000030609 dephosphorylation Effects 0.000 claims description 3
- 238000006209 dephosphorylation reaction Methods 0.000 claims description 3
- 239000003599 detergent Substances 0.000 claims description 3
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 claims description 3
- 210000002889 endothelial cell Anatomy 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 3
- 210000002919 epithelial cell Anatomy 0.000 claims description 3
- 238000003682 fluorination reaction Methods 0.000 claims description 3
- 230000002496 gastric effect Effects 0.000 claims description 3
- 230000013595 glycosylation Effects 0.000 claims description 3
- 238000006206 glycosylation reaction Methods 0.000 claims description 3
- 210000005003 heart tissue Anatomy 0.000 claims description 3
- 230000003834 intracellular effect Effects 0.000 claims description 3
- 210000004020 intracellular membrane Anatomy 0.000 claims description 3
- 108020004999 messenger RNA Proteins 0.000 claims description 3
- 230000002503 metabolic effect Effects 0.000 claims description 3
- 108091070501 miRNA Proteins 0.000 claims description 3
- 239000000693 micelle Substances 0.000 claims description 3
- 239000002679 microRNA Substances 0.000 claims description 3
- 210000004400 mucous membrane Anatomy 0.000 claims description 3
- 210000003205 muscle Anatomy 0.000 claims description 3
- 210000000944 nerve tissue Anatomy 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 210000002381 plasma Anatomy 0.000 claims description 3
- 210000002706 plastid Anatomy 0.000 claims description 3
- 235000019833 protease Nutrition 0.000 claims description 3
- 238000006722 reduction reaction Methods 0.000 claims description 3
- 210000003296 saliva Anatomy 0.000 claims description 3
- 238000004062 sedimentation Methods 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 239000002356 single layer Substances 0.000 claims description 3
- 229940001584 sodium metabisulfite Drugs 0.000 claims description 3
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 3
- 238000000527 sonication Methods 0.000 claims description 3
- 230000002934 lysing effect Effects 0.000 claims description 2
- 230000026731 phosphorylation Effects 0.000 claims description 2
- 238000006366 phosphorylation reaction Methods 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 62
- 238000006243 chemical reaction Methods 0.000 description 24
- 239000008188 pellet Substances 0.000 description 23
- 239000011534 wash buffer Substances 0.000 description 18
- 238000004458 analytical method Methods 0.000 description 16
- 102100030943 Glutathione S-transferase P Human genes 0.000 description 13
- 101001010139 Homo sapiens Glutathione S-transferase P Proteins 0.000 description 13
- 230000008836 DNA modification Effects 0.000 description 12
- 102000007469 Actins Human genes 0.000 description 11
- 108010085238 Actins Proteins 0.000 description 11
- 239000003550 marker Substances 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000002699 waste material Substances 0.000 description 10
- 230000007067 DNA methylation Effects 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 238000007855 methylation-specific PCR Methods 0.000 description 9
- 239000013024 dilution buffer Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 238000002715 modification method Methods 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 108010067770 Endopeptidase K Proteins 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 239000008096 xylene Substances 0.000 description 6
- 238000007399 DNA isolation Methods 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 239000012148 binding buffer Substances 0.000 description 5
- 239000011536 extraction buffer Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 4
- 210000002307 prostate Anatomy 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 238000007400 DNA extraction Methods 0.000 description 3
- 239000013592 cell lysate Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 238000007427 paired t-test Methods 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000005267 prostate cell Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
- 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 1
- 108091029523 CpG island Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000030933 DNA methylation on cytosine Effects 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000006607 hypermethylation Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 238000002205 phenol-chloroform extraction Methods 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000009822 protein phosphorylation Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81787606P | 2006-06-29 | 2006-06-29 | |
US82879006P | 2006-10-10 | 2006-10-10 | |
PCT/US2007/015329 WO2008002680A2 (fr) | 2006-06-29 | 2007-06-29 | Procédé de modification d'une macromolécule sans extraction préalable d'un échantillon |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2009542216A true JP2009542216A (ja) | 2009-12-03 |
Family
ID=38846340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009518328A Pending JP2009542216A (ja) | 2006-06-29 | 2007-06-29 | サンプルから事前に抽出せずに高分子を修飾する方法 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP2041316A4 (fr) |
JP (1) | JP2009542216A (fr) |
KR (1) | KR20090036121A (fr) |
BR (1) | BRPI0713927A2 (fr) |
CA (1) | CA2656327A1 (fr) |
IL (1) | IL196198A0 (fr) |
MX (1) | MX2009000122A (fr) |
WO (1) | WO2008002680A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013533749A (ja) * | 2010-07-15 | 2013-08-29 | キアゲン ゲーエムベーハー | 標的核酸を精製するための方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8298852B2 (en) | 2008-12-29 | 2012-10-30 | Jusung Engineering Co., Ltd. | Thin film type solar cell and method for manufacturing the same |
US20150368636A1 (en) * | 2013-01-30 | 2015-12-24 | Exact Sciences Corporation | Treatment of a sample vessel |
CN107821989B (zh) * | 2017-12-04 | 2020-11-17 | 南京农业大学 | 一种提高类pse鸡胸肉肌原纤维蛋白凝胶品质的糖基化方法 |
WO2022066844A1 (fr) * | 2020-09-24 | 2022-03-31 | Case Western Reserve University | Compositions et procédés de préservation de la méthylation de l'adn |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10304219B3 (de) * | 2003-01-30 | 2004-08-19 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität |
-
2007
- 2007-06-29 MX MX2009000122A patent/MX2009000122A/es unknown
- 2007-06-29 JP JP2009518328A patent/JP2009542216A/ja active Pending
- 2007-06-29 EP EP07810136A patent/EP2041316A4/fr not_active Withdrawn
- 2007-06-29 WO PCT/US2007/015329 patent/WO2008002680A2/fr active Application Filing
- 2007-06-29 KR KR1020097001936A patent/KR20090036121A/ko not_active Application Discontinuation
- 2007-06-29 BR BRPI0713927-6A patent/BRPI0713927A2/pt not_active Application Discontinuation
- 2007-06-29 CA CA002656327A patent/CA2656327A1/fr not_active Abandoned
-
2008
- 2008-12-25 IL IL196198A patent/IL196198A0/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013533749A (ja) * | 2010-07-15 | 2013-08-29 | キアゲン ゲーエムベーハー | 標的核酸を精製するための方法 |
Also Published As
Publication number | Publication date |
---|---|
IL196198A0 (en) | 2009-09-22 |
WO2008002680A2 (fr) | 2008-01-03 |
WO2008002680A3 (fr) | 2008-11-27 |
CA2656327A1 (fr) | 2008-01-03 |
EP2041316A2 (fr) | 2009-04-01 |
MX2009000122A (es) | 2009-01-26 |
EP2041316A4 (fr) | 2009-12-09 |
BRPI0713927A2 (pt) | 2013-01-08 |
KR20090036121A (ko) | 2009-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10738069B2 (en) | Method for isolating nucleic acids | |
JP6689251B2 (ja) | Rnaを高収率で単離するための方法 | |
JP6096660B2 (ja) | 低分子標的核酸を含む標的核酸を高収量で単離するための方法 | |
US9422542B2 (en) | Process for parallel isolation and/or purification of RNA and DNA | |
US20240301396A1 (en) | Method for isolating extracellular nucleic acids using anion exchange particles | |
US20080213870A1 (en) | Methods for obtaining modified DNA from a biological specimen | |
JP2012502632A (ja) | スモールrnaの単離法 | |
WO2007100934A2 (fr) | Procédés et compositions permettant d'isoler rapidement de petites molécules d'arn | |
TW201920957A (zh) | 使用雙液相系統以分離﹑純化和/或濃縮短核酸片段的方法 | |
JP2006517225A (ja) | 核酸抽出のための生物学的試料の化学処理および該処理用のキット | |
WO2009018034A1 (fr) | Procédé amélioré de purification de l'acide nucléique | |
EP2473596A2 (fr) | Procédés et compositions de lyse chimique directe | |
US20090042290A1 (en) | Method of modifying a macromolecule without prior extraction from a sample | |
JP2009542216A (ja) | サンプルから事前に抽出せずに高分子を修飾する方法 | |
JP4441262B2 (ja) | 改良された核酸の単離方法 | |
Siddiqui et al. | A solid-phase method for preparing human DNA from urine for diagnostic purposes | |
CN117802203B (zh) | 一种基于crispr技术降低福尔马林固定石蜡包埋样本中宿主核酸占比的方法及其试剂盒 | |
JP2016158558A (ja) | Dnaとrnaの単離方法 |